PulseTrendingJournal ClubResearchersJournalsExplore
Instagram
HomeTrendingJournal ClubExplore
Synapse
⌘+K
Synapse
May 2, 2024Cancer Research

Abstract PO1-17-08: Post-approval treatment patterns and tolerability of neratinib in HER2+ early-stage breast cancer

View Full Paper
Ask AI
Bookmark
Share

Authors

KMKelly McCannNHNadia HarbeckDTDebu Tripathy

Discussion

Loading...

Member takes

Overview

Key Points

Key points are not available for this paper at this time.

Cite This Study

McCann et al. (2024) studied this question.

synapsesocial.com/papers/68e6be91b6db64358763e52ehttps://doi.org/10.1158/1538-7445.sabcs23-po1-17-08
View Full Paper
Ask AI
Bookmark
Share